|
SFRS13A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.255500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.443700E-03 |
| Normal-vs-Stage2 |
2.173400E-01 |
| Normal-vs-Stage3 |
4.520000E-03 |
| Normal-vs-Stage4 |
6.943800E-03 |
| Stage1-vs-Stage2 |
7.091800E-01 |
| Stage1-vs-Stage3 |
2.819000E-01 |
| Stage1-vs-Stage4 |
5.074400E-01 |
| Stage2-vs-Stage3 |
3.094200E-01 |
| Stage2-vs-Stage4 |
4.711400E-01 |
| Stage3-vs-Stage4 |
7.281000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.357000E-03 |
| Normal-vs-AfricanAmerican |
7.385600E-04 |
| Normal-vs-Asian |
3.940800E-01 |
| Caucasian-vs-AfricanAmerican |
9.866400E-02 |
| Caucasian-vs-Asian |
6.988000E-02 |
| AfricanAmerican-vs-Asian |
6.283900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.664100E-03 |
| Normal-vs-Female |
3.124200E-02 |
| Male-vs-Female |
1.454010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.250200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.325800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.896640E-03 |
| Normal-vs-Age(81-100Yrs) |
1.486190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.412200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.706800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.988200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.263600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.659200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.765600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.218800E-01 |
| Normal-vs-Grade 2 |
1.598990E-01 |
| Normal-vs-Grade 3 |
1.980470E-04 |
| Normal-vs-Grade 4 |
4.362900E-04 |
| Grade 1-vs-Grade 2 |
2.394400E-01 |
| Grade 1-vs-Grade 3 |
9.900300E-03 |
| Grade 1-vs-Grade 4 |
2.776000E-02 |
| Grade 2-vs-Grade 3 |
2.638700E-03 |
| Grade 2-vs-Grade 4 |
6.620300E-03 |
| Grade 3-vs-Grade 4 |
4.591600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.008400E-01 |
| Normal-vs-ccB subtype |
5.434600E-04 |
| ccA subtype-vs-ccB subtype |
1.035290E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.521620E-02 |
| Normal-vs-N1 |
9.451800E-02 |
| N0-vs-N1 |
7.510800E-01 |
|
|
